Literature DB >> 26722412

A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer.

Jing Feng1, Yue Sun1, Er-Bao Zhang2, Xi-Yi Lu1, Shi-Dai Jin1, Ren-Hua Guo1.   

Abstract

Long non-coding RNAs (lncRNAs) are a novel class of RNA molecules defined as transcripts longer than 200 nucleotides that lack protein coding potential. LncRNA IRAIN has been verified that it is related to acute myeloid leukemia (AML) and breast cancer. However, there was no study to clarify whether it is involved in non-small cell lung cancer (NSCLC). Here, we demonstrated IRAIN as a tumor promoter in NSCLC. Its expression level was remarkably upregulated in NSCLC tissues and connected with tumor size and smoking status. Knockdown of IRAIN suppressed NSCLC cells proliferation in vitro. These data identify IRAIN as a novel promoting gene, which plays a vital role in tumorigenesis of NSCLC.

Entities:  

Keywords:  A549; IRAIN; Long non-coding RNA; gene therapy; non-small cell lung cancer

Mesh:

Substances:

Year:  2015        PMID: 26722412      PMCID: PMC4680357     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  35 in total

1.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses.

Authors:  Moran N Cabili; Cole Trapnell; Loyal Goff; Magdalena Koziol; Barbara Tazon-Vega; Aviv Regev; John L Rinn
Journal:  Genes Dev       Date:  2011-09-02       Impact factor: 11.361

2.  Multiple resistant factors in lung cancer with primary resistance to EGFR-TK inhibitors confer poor survival.

Authors:  Go Woon Kim; Joon Seon Song; Chang-Min Choi; Jin Kyung Rho; Sun Ye Kim; Se Jin Jang; Young Soo Park; Sung-Min Chun; Woo Sung Kim; Jung-Shin Lee; Sang-We Kim; Dae Ho Lee; Jae Cheol Lee
Journal:  Lung Cancer       Date:  2015-02-12       Impact factor: 5.705

3.  Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β-cell functions, and β-cell proliferation in male mice.

Authors:  Jun Shirakawa; Tomoko Okuyama; Eiko Yoshida; Mari Shimizu; Yuka Horigome; Takayuki Tuno; Moe Hayasaka; Shiori Abe; Masahiro Fuse; Yu Togashi; Yasuo Terauchi
Journal:  Endocrinology       Date:  2014-04-08       Impact factor: 4.736

4.  Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.

Authors:  Niels Reinmuth; Wenbiao Liu; Fan Fan; Young D Jung; Syed A Ahmad; Oliver Stoeltzing; Corazon D Bucana; Robert Radinsky; Lee M Ellis
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

5.  MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.

Authors:  Wei Xu; Meng Hang; Chen-Ye Yuan; Fu-Lin Wu; Shu-Bo Chen; Kai Xue
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 6.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

7.  Time trends in cancer mortality in China: 1987-1999.

Authors:  Ling Yang; Donald M Parkin; Liandi Li; Yude Chen
Journal:  Int J Cancer       Date:  2003-09-20       Impact factor: 7.396

Review 8.  Insulin-like growth factors and cancer.

Authors:  Gregor Fürstenberger; Hans-Jörg Senn
Journal:  Lancet Oncol       Date:  2002-05       Impact factor: 41.316

9.  The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression.

Authors:  Thomas Derrien; Rory Johnson; Giovanni Bussotti; Andrea Tanzer; Sarah Djebali; Hagen Tilgner; Gregory Guernec; David Martin; Angelika Merkel; David G Knowles; Julien Lagarde; Lavanya Veeravalli; Xiaoan Ruan; Yijun Ruan; Timo Lassmann; Piero Carninci; James B Brown; Leonard Lipovich; Jose M Gonzalez; Mark Thomas; Carrie A Davis; Ramin Shiekhattar; Thomas R Gingeras; Tim J Hubbard; Cedric Notredame; Jennifer Harrow; Roderic Guigó
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

10.  P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression.

Authors:  E-b Zhang; D-d Yin; M Sun; R Kong; X-h Liu; L-h You; L Han; R Xia; K-m Wang; J-s Yang; W De; Y-q Shu; Z-x Wang
Journal:  Cell Death Dis       Date:  2014-05-22       Impact factor: 8.469

View more
  10 in total

1.  Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer.

Authors:  Yifan Lian; Juan Wang; Jing Feng; Jie Ding; Zhonghua Ma; Juan Li; Peng Peng; Wei De; Keming Wang
Journal:  Tumour Biol       Date:  2016-09-19

2.  Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer.

Authors:  Rui Wang; Lutao Du; Xiaoyun Yang; Xiumei Jiang; Weili Duan; Suzhen Yan; Yujiao Xie; Yuntao Zhu; Qingliang Wang; Lili Wang; Yongmei Yang; Chuanxin Wang
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-03       Impact factor: 4.553

3.  PLOD3 regulates the expression of YAP1 to affect the progression of non-small cell lung cancer via the PKCδ/CDK1/LIMD1 signaling pathway.

Authors:  Wei-Hao Li; Kai Huang; Feng-Biao Wen; Guang-Hui Cui; Hai-Zhou Guo; Song Zhao
Journal:  Lab Invest       Date:  2022-01-17       Impact factor: 5.662

4.  Long non-coding RNA DLGAP1-AS1 modulates the development of non-small-cell lung cancer via the microRNA-193a-5p/DTL axis.

Authors:  Xudong Pan; Siwen Chen; Lu Ye; Shenjie Xu; Ling Wang; Yi Sun
Journal:  Lab Invest       Date:  2022-10-01       Impact factor: 5.502

5.  Long noncoding RNA IRAIN acts as tumor suppressor via miR-125b in multiple myeloma.

Authors:  Yanxia Jiang; Jian Chen; Guoan Chen
Journal:  Oncol Lett       Date:  2019-10-21       Impact factor: 2.967

Review 6.  The involvement of lncRNAs in the development and progression of pancreatic cancer.

Authors:  Li Duguang; He Jin; Qian Xiaowei; Xu Peng; Wang Xiaodong; Li Zhennan; Qian Jianjun; Yao Jie
Journal:  Cancer Biol Ther       Date:  2017-11-27       Impact factor: 4.742

7.  Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.

Authors:  Yujiao Xie; Yi Zhang; Lutao Du; Xiumei Jiang; Suzhen Yan; Weili Duan; Juan Li; Yao Zhan; Lili Wang; Shujun Zhang; Shuhai Li; Lishui Wang; Shuo Xu; Chuanxin Wang
Journal:  Mol Oncol       Date:  2018-03-25       Impact factor: 6.603

8.  Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition.

Authors:  Lingling Pian; Xue Wen; Lihua Kang; Zhaozhi Li; Yuanyuan Nie; Zhonghua Du; Dehai Yu; Lei Zhou; Lin Jia; Naifei Chen; Dan Li; Songling Zhang; Wei Li; Andrew R Hoffman; Jingnan Sun; Jiuwei Cui; Ji-Fan Hu
Journal:  Mol Ther Nucleic Acids       Date:  2018-05-03       Impact factor: 8.886

9.  Long non-coding RNAs function as novel predictors and targets of non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Yanlu Xiong; Tao Wang; Mingxing Wang; Jinbo Zhao; Xiaofei Li; Zhipei Zhang; Yongsheng Zhou; Jiabao Liu; Lintao Jia; Yong Han
Journal:  Oncotarget       Date:  2018-01-04

10.  Expression and Effects of Long Non-Coding RNA, LINC01124, in Non-Small Cell Lung Cancer.

Authors:  Zi-Bo Wang; Hong-Yan Zhang; Ji-Bin Lu
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.